abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기업 응답

2012년 1월 11일

저자:
Abbott Laboratories

Abbott Laboratories statement regarding “Global Kaletra Campaign”

Abbott provides its HIV medicines at tiered prices for countries in greatest need and has put extensive measures in place to ensure access for those who need our medicines. This approach balances the needs of patients, countries’ levels of economic development, and our continued investment in the development and uninterrupted supply of quality anti-retroviral medicines.

이는 다음에 대한 응답입니다

"B-HRD Project Launches Special Feature on 'Big Pharma' and Access to HIV/AIDS Drugs"

이야기 2011년 12월 19일

타임라인